Alx Oncology (ALXO)Officer sold ~$391
Shelly Pinto, Officer at Alx Oncology, sold ~$391 of Alx Oncology shares.
- ~$391
- Approx. value · 611 sh @ $0.6404
- 89K
- Holds after · shares reported
- Traded
- Aug 15, 2025
- Filed
- Aug 19, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 30, 2025InsiderOfficer sold ~$659 of ALXO shares in the open market
- Jul 7, 2025InsiderOfficer sold ~$905 of ALXO shares in the open market
- Aug 15, 2025 · this disclosureInsiderOfficer sold ~$391 of ALXO shares in the open market
What came next
- Aug 15, 2025InsiderCEO sold ~$1.5K of ALXO shares in the open market
- Aug 18, 2025InsiderCFO purchased ~$58K of ALXO shares in the open market
- Sep 11, 2025Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On September 11, 2025, Barbara Klencke, M.D. provided notice that she would resign as a member of the Board of Directors (the “Board”) of ALX Oncology Holdings Inc. (the “Company”) and all committees thereof effective September 17, 2025, in connection with the managerial changes referenced in Item 8.01 below.”
- Sep 16, 2025InsiderCEO purchased ~$22K of ALXO shares in the open market
- Sep 17, 2025InsiderCEO purchased ~$77K of ALXO shares in the open market
- Nov 7, 2025Company filing · Form 8-K · ResultsReported its results
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Alx Oncology
For Alx Oncology, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALXO page.
Other recent filings by Shelly Pinto, SVP, FINANCE AND CAO
- SEC Form 4 at Alx Oncology (ALXO)Aug 18, 2026
- SEC Form 4 at Alx Oncology (ALXO)Jul 6, 2026
- SEC Form 4 at Alx Oncology (ALXO)Mar 23, 2026
- SEC Form 4 at Alx Oncology (ALXO)Feb 20, 2026
- SEC Form 4 at Alx Oncology (ALXO)Jan 7, 2026
The full history of Shelly Pinto, SVP, FINANCE AND CAO is on the profile page.
How this filing works
Other disclosures at Alx Oncology
- SEC Form 4Aug 18, 2026
- SEC Form 4Aug 18, 2026
- SEC Form 4Jul 6, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 4Mar 23, 2026
- SEC Form 4Mar 23, 2026
Everything OQRO holds on this company is on its ALXO page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
